Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Fludarabine Phosphate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 199,100Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA updates label of 33-year-old cancer drug with dose & warning
    FDA updates label of 33-year-old cancer drug with dose & warning

    21 Nov 2024

    // ENDPTS

    https://endpts.com/fda-updates-label-of-33-year-old-cancer-drug-with-new-dose-and-warning/

    ENDPTS
    21 Nov 2024
    Share Share
    FDA Updates Label Of 33-Year-Old Cancer Drug With Warning
    FDA Updates Label Of 33-Year-Old Cancer Drug With Warning

    20 Nov 2024

    // ENDPTS

    https://endpts.com/fda-updates-label-of-33-year-old-cancer-drug-with-new-dose-and-warning/

    ENDPTS
    20 Nov 2024
    Share Share
    Nkarta's cell therapy needs specific pre-conditioning
    Nkarta's cell therapy needs specific pre-conditioning

    27 Jun 2023

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/nkarta-touts-cell-therapy-effectiveness-specific-lymphodepletion-regiment-durability

    Max Bayer FIERCE BIOTECH
    27 Jun 2023
    Share Share
    CRISPR Therapeutics' CAR-T Cancer Therapy Shows Early Promise
    CRISPR Therapeutics' CAR-T Cancer Therapy Shows Early Promise

    13 Oct 2021

    // Mark Terry BIOSPACE

    https://www.biospace.com/article/crispr-therapeutics-announces-promising-data-for-its-car-t-cancer-therapy/?s=71

    Mark Terry BIOSPACE
    13 Oct 2021
    Share Share
    Enforcement Report - Week of September 1, 2021
    Enforcement Report - Week of September 1, 2021

    01 Sep 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-1-2021-1630499458.pdf

    FDA
    01 Sep 2021
    Share Share
    CBMG' Novel Anti-CD20 CAR-T Cell Therapy Shows Promising Safety and Efficacy
    CBMG' Novel Anti-CD20 CAR-T Cell Therapy Shows Promising Safety and Efficacy

    10 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cbmg-holdings-novel-anti-cd20-car-t-cell-therapy-shows-promising-safety-and-efficacy-in-relapsedrefractory-b-cell-non-hodgkin-lymphoma-patients-following-relapse-to-an-anti-cd19-car-t-therapy-301310049.html

    PRNEWSWIRE
    10 Jun 2021
    Share Share